Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
ALUR
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
N/A
-2.17
vs -0.12
Q3.23
N/A
-15.25
vs -0.29
Q4.23
N/A
-15.75
vs -0.11
Q1.24
+576%
2.75
vs -0.58
Q2.24
+112%
0.25
vs -2.17
Q3.24
N/A
-3.50
vs -15.25
Q4.24
N/A
-7.00
vs -15.75
Q1.25
-84%
0.43
vs 2.75
Q2.25
N/A
-0.81
vs 0.25
Q3.25
N/A
-0.65
vs -3.50
Sales Growth
YoY
Current
Estimates
Q2.23
-20%
13M vs 16.3M
Q3.23
+13%
18.2M vs 16.1M
Q4.23
-57%
8.2M vs 19.2M
Q1.24
-33%
9.4M vs 14.1M
Q2.24
-9%
11.8M vs 13M
Q3.24
-71%
5.4M vs 18.2M
Q4.24
-32%
5.6M vs 8.2M
Q1.25
-41%
5.6M vs 9.4M
Q2.25
-50%
5.9M vs 11.8M
Q3.25
+40%
7.5M vs 5.4M
Return on Equity
QoQ
Q2.23
+20%
0.2
vs 0.2
Q3.23
+41%
0.41
vs 0.2
Q4.23
+27%
0.27
vs 0.41
Q1.24
-8%
-0.08
vs 0.27
Q2.24
+3%
0.03
vs -0.08
Q3.24
+14%
0.14
vs 0.03
Q4.24
+26%
0.26
vs 0.14
Q1.25
-11%
-0.11
vs 0.26
Institutionnal Ownership
QoQ
Q3.23
24
24
vs NA
NA
Q4.23
26
26
vs 24
8%
Q1.24
26
26
vs 26
NA
Q2.24
34
34
vs 26
31%
Q3.24
28
28
vs 34
-18%
Q4.24
24
24
vs 28
-14%
zacks.com
11 hours ago
zacks.com
12 hours ago
seekingalpha.com
14 hours ago
businesswire.com
16 hours ago
Quote Panel
Key Metrics
Forecast
675%2026-Revenue
-224%2026-EPS
-258%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
0.00(-100.00%)
Number of analyst
0
Last analyst upgrade/downgrade
Chardan Capital
downgradePrevious: Buy
2024-11-14
Now: Positive
Cowen & Co.
initialisePrevious: Not converted
2024-10-02
Now: Buy
Chardan Capital
initialisePrevious: Not converted
2024-04-04
Now: Buy
Relative Strength
ALUR
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
NYSE
Unprofitable
EPS improving
Unprofitable
EPS improving
-0.10 ( -4.13%)
Relative Strenght
2
Volume Buzz
-87%
Earning Acce
No
Dist 52w H.
96%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How ALUR compares to sector?
ALUR
0x
